Please rate this video

IMW 2019 | MM: BTD plus a monoclonal antibody

Please rate this video

Amrita Krishnan

Amrita Krishnan, MD, City of Hope, Duarte, CA, outlines what was discussed at the ‘treatment of newly diagnosed myeloma transplant eligible’ plenary session she chaired at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The CASSIOPEIA study (NCT02541383) was the key point of discussion.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter